Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate 00904-7009-06
- Manufacturer
- Major Pharmaceuticals
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- June 27, 2014
- Listing Expires
- December 31, 2027
- Application
- ANDA203326
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
| Naloxone Hydrochloride Dihydrate | .5 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Selected Package
00904-7009-06Selected50 BLISTER PACK in 1 CARTON (0904-7009-06) / 1 TABLET in 1 BLISTER PACK
External Resources